Recently stock market analysts have updated their consensus ratings on shares of AngioDynamics, Inc. (NASDAQ:ANGO). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/08/2016 – Piper Jaffray began new coverage on AngioDynamics, Inc. giving the company a “neutral” rating. They now have a USD 12 price target on the stock.

04/08/2016 – AngioDynamics, Inc. had its “overweight” rating reiterated by analysts at KeyBanc. They now have a USD 16 price target on the stock.

04/05/2016 – AngioDynamics, Inc. was downgraded to “hold” by analysts at Canaccord Genuity. They now have a USD 13 price target on the stock.

11/10/2015 – AngioDynamics, Inc. was downgraded to “market perform” by analysts at Raymond James.

09/23/2015 – Sidoti began new coverage on AngioDynamics, Inc. giving the company a “neutral” rating. They now have a USD 14.5 price target on the stock.

03/27/2015 – AngioDynamics, Inc. had its “hold” rating reiterated by analysts at Zacks. They now have a USD 20 price target on the stock.

04/17/2014 – AngioDynamics, Inc. was downgraded to “hold” by analysts at TheStreet.

01/10/2014 – AngioDynamics, Inc. was downgraded to “hold” by analysts at Jefferson Research.

AngioDynamics, Inc. has a 50 day moving average of 11.97 and a 200 day moving average of 11.66. The stock’s market capitalization is 452.11M, it has a 52-week low of 9.71 and a 52-week high of 17.00.

The share price of the company (NASDAQ:ANGO) was up +1.38% during the last trading session, with a high of 12.49 and the volume of AngioDynamics, Inc. shares traded was 146555.

View other investors thoughts on AngioDynamics, Inc. on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.